Expanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic Mastocytosis
Cogent Biosciences, Inc.
Cogent Biosciences, Inc.
City of Hope Medical Center
UNC Lineberger Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Cogent Biosciences, Inc.
Blueprint Medicines Corporation
Blueprint Medicines Corporation
Novartis
Deciphera Pharmaceuticals, LLC
Eastern Cooperative Oncology Group
Blueprint Medicines Corporation
GT Biopharma, Inc.
Blueprint Medicines Corporation
Rutgers, The State University of New Jersey
Northwestern University
Blueprint Medicines Corporation
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Stanford University
Novartis
Stanford University
Stanford University
Wake Forest University Health Sciences
Children's Oncology Group
Wake Forest University Health Sciences
Stanford University
Fred Hutchinson Cancer Center
Wake Forest University Health Sciences
Fred Hutchinson Cancer Center
Vanderbilt University Medical Center
Mayo Clinic
Alliance for Clinical Trials in Oncology
Adelphi Values LLC
Novartis
Children's Oncology Group
City of Hope Medical Center
Rutgers, The State University of New Jersey
SWOG Cancer Research Network
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)